Novartis Launches 3-Day Feline NSAID



Published:

Novartis Animal Health launched Onsior (robenacoxib) tablets, a three-day non-steroidal anti-inflammatory drug for postoperative cats, the Greensboro, N.C., company reported today.

The drug is indicated for the control of postoperative pain and inflammation associated with orthopedic surgery, ovariohysterectomy and castration. It is the first multidose oral NSAID to be approved for cats, Novartis reported.

The drug’s short blood half-life causes the active ingredient to be quickly eliminated from the blood while persisting longer at the site of inflamed tissue, allowing for once-a-day administration for up to three days, the company reported.

Side effects observed during a clinical field trial and six-month safety study included surgical site bleeding, infected surgery sites, lethargy, vomiting and inappetence.

The drug is indicated for cats weighing 5.5 pounds or heavier and at least 6 months old for a maximum of three days. The drug should not be used in cats that have a hypersensitivity to robenacoxib or known intolerance to NSAIDs and should not be administered in conjunction with any other oral or injectable NSAID or corticosteroid, according to Novartis.

 <HOME>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Purdue’s Trustees Give Green Light on $60 Million Ag, Life Sciences Facility

The Board of Trustees also took actions to advance an equine center in Shelbyville, Ind.

FTC Open to Wider Veterinary Drug Market

Veterinarians face growing competition from retail outlets, and the trend is likely to continue for better or worse.

K-State Unveils Test for New Dog Flu Strain

The Veterinary Diagnostic Laboratory uses sequencing to identify H3N2 and help in the search for a vaccine.

Add your comment:
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module